Search Results 901-910 of 11882 for Lupus

  1. Atezolizumab Immunotherapy in Patients With Advanced NSCLC (AJCC 7th Edition) - Mayo Clinic

    History of active autoimmune disease, including but not limited to systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular ...

  2. Vaccines for adults: Which do I need? - Mayo Clinic

    What vaccines do adults need? · COVID-19. · Flu. · Hepatitis B. · Human papillomavirus (HPV). · Pneumococcal. · Respiratory syncytial virus (RSV). · Shingles. · Tetanus ...

  3. Radiation Therapy with Durvalumab or Cetuximab to Treat Patients with Locoregionally Advanced Head and Neck Cancer who Cannot Take Cisplatin - Mayo Clinic

    ... lupus erythematosus, Sarcoidosis syndrome, or Wegener syndrome [granulomatosis with polyangiitis, Graves' disease, rheumatoid arthritis, hypophysitis ...

  4. A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma - Mayo Clinic

    Inclusion Criteria: Signed informed consent. Diagnosis of MCC with distant metastatic disease as a component of tumor burden and no more than 3 prior ...

  5. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

    Autoimmune diseases include, but are not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis ...

  6. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. ALEX Study: A Randomized, Phase III Study Comparing Alectinib with Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Patients - Mayo Clinic

    ALEX Study: A Randomized, Phase III Study Comparing Alectinib with Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small ...

  8. A Study of Imaging and Systemic Markers in Patients with Epilepsy - Mayo Clinic

    The purpose of this study is to investigate if blood and/or MRI markers of inflammation and immune system activation may show changes in relation to when you ...

  9. Nivolumab shows significant benefit for Hodgkin’s lymphoma in Mayo Clinic co-led phase I study

    — A phase I clinical trial of nivolumab found that the immune-boosting drug is a highly effective therapy for Hodgkin's lymphoma. The multi-institution study, ...

  10. Selective Vulnerability of the Hippocampus - Translational Neuropathology Laboratory - Mayo Clinic Research

    The Translational Neuropathology Lab of Melissa E. Murray, Ph.D., at Mayo Clinic studies genetic causes of hippocampal involvement in Alzheimer's disease.